Priority Date: 09.07.12 (US 201261669534P)

BIOMARKERS ASSOCIATED WITH CDK INHIBITORS

  • Application ID: EP13735529
  • Status: The patent has been granted

Applicants

Technology company logo small
Technology Company
Research organisation logo small
Research Organisation

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Novartis Pharma AG is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 09.07.2012 - Priority Date (US 201261669534P)
  • 16.01.2014 - Publication A1 (WO2014011398)
  • 13.05.2015 - Publication A1 (EP2870261)
  • 06.12.2017 - Publication B1 (EP2870261)

IPC Classification